Literature DB >> 16418150

Nonketotic hyperosmolar coma in a patient with type 1 diabetes-related diabetic nephropathy: case report.

Ekrem Dogan1, Reha Erkoc, Hayriye Sayarlioglu, Akif Buyukbese.   

Abstract

Nonketotic hyperosmolar coma (NHC) is characterized by severe hyperglycemia; absence of, or only slight ketosis; nonketotic acidosis; severe dehydration; depressed sensorium or frank coma; and various neurologic signs. This condition is uncommon in type 1 diabetes. Because of little or no osmotic diuresis in patients with diabetic nephropathy, increases in plasma osmolality and therefore the likelihood of neurologic symptoms are limited. A 20-year-old male patient with type 1 diabetes with chronic kidney disease on conservative treatment (glomerular filtration rate [GFR], 18 mL/dk) presented with acute nonketotic hyperosmolar syndrome. The patient was admitted presenting with thirst, fatigue, and drowsiness. Blood biochemistry levels were urea 87 mg/dL, creatinine 5.09 mg/dL, glucose 830 mg/dL, glycosylated hemoglobin (HbA1c) 8%, C peptide <0.3 ng/mL, sodium 131 mmol/L, chloride 93 mmol/L, potassium 5.2 mmol/L, and calculated serum osmolality 385 mOsm/kg. The presumptive diagnosis on admission was nonketotic hyperosmolar syndrome precipitated by urinary infection. This is the first case report of hyperosmolar coma in a patient with type 1 diabetes with chronic kidney disease.

Entities:  

Mesh:

Year:  2005        PMID: 16418150     DOI: 10.1007/bf02849861

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  4 in total

1.  Context-dependent regulation of Th17-associated genes and IFNγ expression by the transcription factor NFAT5.

Authors:  Maria Alberdi; Marcos Iglesias; Sonia Tejedor; Ramón Merino; Cristina López-Rodríguez; Jose Aramburu
Journal:  Immunol Cell Biol       Date:  2016-08-01       Impact factor: 5.126

Review 2.  Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.

Authors:  Jose Aramburu; Cristina López-Rodríguez
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

3.  Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice.

Authors:  Beatriz Morancho; Jordi Minguillón; Jeffery D Molkentin; Cristina López-Rodríguez; Jose Aramburu
Journal:  BMC Mol Biol       Date:  2008-01-25       Impact factor: 2.946

4.  The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress.

Authors:  Katherine Drews-Elger; M Carmen Ortells; Anjana Rao; Cristina López-Rodriguez; Jose Aramburu
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.